The triterpenoid lupeol attenuates allergic airway inflammation in a murine model
- 30 September 2008
- journal article
- Published by Elsevier BV in International Immunopharmacology
- Vol. 8 (9), 1216-1221
- https://doi.org/10.1016/j.intimp.2008.04.011
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Pharmacotherapy of AsthmaAmerican Journal of Pharmaceutical Education, 2007
- Asthma end points and outcomes: What have we learned?Journal of Allergy and Clinical Immunology, 2006
- The natural history of asthmaJournal of Allergy and Clinical Immunology, 2006
- Airway Remodeling in Asthma: Therapeutic Implications of MechanismsPhysiology, 2005
- T cell activation, from atopy to asthma: more a paradox than a paradigmAllergy, 2003
- Infection withStrongyloides venezuelensisInduces Transient Airway Eosinophilic Inflammation, an Increase in Immunoglobulin E, and Hyperresponsiveness in RatsInfection and Immunity, 2002
- Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthmaThorax, 2002
- Mast cell function modulating IgE-mediated allergyAllergology International, 1999
- An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergenThorax, 1998
- T cells and eosinophils in the pathogenesis of asthmaImmunology Today, 1992